This year’s meeting will be held in conjunction with the National Adult Immunization Summit in Atlanta, GA on May 15-17. Ms. Ofstead will present findings from the Worksite Influenza Vaccination Study and participate in a panel discussion about ways to reach priority populations with annual influenza vaccination. Sanofi Pasteur provided financial support and Fluzone® (Influenza Virus Vaccine) for this study.
Handouts from Ms. Ofstead’s presentation are available at http://www.preventinfluenza.org/nivs_2012/NIVS-3_ofstead_worksite.pdf. More information about the National Influenza Vaccine Summit is available at http://preventinfluenza.org/nivs.asp.